Shares of Red Violet, Inc. (NASDAQ:RDVT – Get Free Report) traded down 5.3% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $36.61 and last traded at $36.72. 49,557 shares were traded during trading, an increase of 0% from the average session volume of 49,390 shares. The stock had previously closed at $38.78.
Specifically, President James Patrick Reilly sold 10,000 shares of Red Violet stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $37.25, for a total transaction of $372,500.00. Following the completion of the sale, the president now owns 272,124 shares of the company’s stock, valued at $10,136,619. The trade was a 3.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Red Violet Stock Down 1.2 %
The stock has a 50-day moving average of $30.57 and a 200 day moving average of $26.87. The stock has a market cap of $503.20 million, a PE ratio of 101.36 and a beta of 1.46.
Hedge Funds Weigh In On Red Violet
Red Violet Company Profile
Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.
Featured Articles
- Five stocks we like better than Red Violet
- Canadian Penny Stocks: Can They Make You Rich?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Using the MarketBeat Dividend Yield Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Red Violet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Red Violet and related companies with MarketBeat.com's FREE daily email newsletter.